“…(3) More recently, NF-kB constitutive activity, as observed in Hodgkin's lymphoma cells, has been associated with a mutation in the gene encoding the IkB-inhibitor (Krappmann et al, 1999), which can lead to impaired control of NF-kB activity and hence to enhanced nuclear activity (Bours et al, 2000). The NF-kB transcription factor is activated in response to a broad range of preapoptotic stimuli (Osborn et al, 1989;Brach et al, 1991;Schreck et al, 1991), dissociates from its attached inhibitory protein IkB and translocates to the nucleus to induce the expression of target genes, including several well-known antiapoptotic genes such as TNF-receptor-associated factor 1 (TRAF1), and TRAF2, cIAPs, manganese superoxide dismutase, A20 and IEX-IL (Wang et al, 1998;Wu et al, 1998). Although NF-kB has been previously shown to be expressed at high levels in human colonic adenomatous polyps, our investigations have demonstrated for the first time (to the best of our knowledge) that IKKa, cytoplasmic inactive NF-kB-p65 protein and putative active endonuclear NF-kB-p65 protein are significantly increased in malignant colorectal epithelial cells.…”